Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,445
Total Claims
$4.0M
Drug Cost
938
Beneficiaries
$4,283
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-97%
Opioid rate vs peers
0.1% vs 2.2% avg
+204%
Cost per patient vs peers
$4,283 vs $1,411 avg
+83%
Brand preference vs peers
19.5% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$46
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,555 claims · $3.6M
Generic: 14,703 claims · $356K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 358 | $608K |
| Sitagliptin Phos/Metformin Hcl | 339 | $524K |
| Sitagliptin Phosphate | 245 | $361K |
| Linaclotide | 164 | $190K |
| Dulaglutide | 106 | $175K |
| Dapagliflozin Propanediol | 97 | $156K |
| Semaglutide | 109 | $153K |
| Icosapent Ethyl | 171 | $152K |
| Apixaban | 69 | $99K |
| Semaglutide | 41 | $84K |
| Linagliptin | 68 | $81K |
| Empagliflozin/Metformin Hcl | 47 | $80K |
| Sodium Zirconium Cyclosilicate | 67 | $79K |
| Dapaglifloz Propaned/Metformin | 39 | $62K |
| Budesonide/Formoterol Fumarate | 117 | $56K |
Prescribing Profile
Patient Profile
74
Avg Age
63%
Female
1.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data